🔎 Trials Near Me

Akèy › Kansè lestomak › Texas › San Antonio

Etid klinik pou Kansè lestomak nan San Antonio, TX

19 etid pou Kansè lestomak ap chèche patisipan nan sit nan ak bò kote San Antonio (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Audie L Murphy VA Hospital, San Antonio
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Ap rekriteFaz 1
  • NEXT Oncology - PARENT, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07360314

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • NEXT Oncology San Antonio, San Antonio
  • START Texas, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Ap rekriteFaz 1/2
  • START South Texas Accelerated Research Therapeutics, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05267626

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • NEXT Oncology, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07705334

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • START - San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Ap rekriteFaz 1
  • NEXT San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07227168

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07115043

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • UT Health Mays Cancer Center, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Clinical Trial Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07749586

IDOV-Immune for Advanced Solid Tumors

Ap rekriteFaz 1
  • South Texas Accelerated Research Therapeutics, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06910657

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Ap rekriteFaz 1
  • NEXT Virginia, LLC, San Antonio
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Ap rekriteFaz 1
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • START San Antonio, LLC., San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06657144

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • NEXT Oncology, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06239194

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Ap rekriteFaz 1
  • Dren Investigational Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

Etid Kansè lestomak nan lòt vil

Lòt etid nan San Antonio

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.